Form D · Pharmaceuticals
NephroGenex, Inc.
Raleigh, NC · CIK 0001338095
Offering snapshot reported Nov 13, 2015 · SEC filing
- Reported sold
- $5.5M Offering amount: $28.5M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 3, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2015 | Initial | $5,500,000 | No comparison | 14 | SEC filing |
| Jul 21, 2010 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
| May 22, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 30, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $358K
- Finders' fees
- $0
- Form D file number
- 021-251166
If all short term warrants are exercised the total proceeds to the Company will be approximately $28.5 million.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 | H.C. Wainwright & Co., LLC · CRD 375 |
Source: Form D, filed Nov 13, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Wesley Fox | Director, Executive |
| John Hamill | Executive |
| Pierre Legault | Director, Executive |
| Mark Leschly | Director |
| Richard Markham | Director |
| James Mitchum | Director |
| Jaikrishna Patel | Executive |
| David R. Ramsay | Director |
| Robert Seltzer | Director |
| Eugen Steiner | Director |
| Marco Taglietti | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3200 Beechleaf Court Suite 900
Raleigh, NC, 27604
Raleigh, NC, 27604